Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.
about
Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines.Sphingolipid pathway regulates innate immune responses at the fetomaternal interface during pregnancyNatural killer cells and their activation status in normal pregnancy.Immune etiology of recurrent pregnancy loss and its diagnosis.Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis.British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice.Enough! Stop the arguments and get on with the science of natural killer cell testing.First trimester PBMC microRNA predicts adverse pregnancy outcome.Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.Intravenous immunoglobulin for repeated IVF failure and unexplained infertility.Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.The role of immunological testing and intervention in reproductive medicine: A fertile collaboration?A meta-analysis of atosiban supplementation among patients undergoing assisted reproduction.Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.Immune modulation of i.v. immunoglobulin in women with reproductive failure.
P2860
Q33575554-94F7FC76-1442-45B1-A3BF-2DD8FFC2092AQ35002828-3C4BAD9D-D4A7-4564-94E4-82828E15A92EQ35100173-3D840E53-B9A5-4848-8EBB-E2FD3D471CA9Q37989551-9380BB74-655D-44A4-A7B7-84E1777C23CDQ38163096-FCB113D0-99F7-4C09-A2B5-7B3AE19197ADQ38297114-CF46B4AD-175A-4102-86E2-914F3FAA7DE5Q38466583-2E03EE50-0D3D-4804-A53E-65A1207801F2Q39168120-DAC5BE9A-0722-42B0-837A-F39C47F1870AQ39235290-1FC38BDE-46F0-4DDD-8EE6-D9364725EADEQ43736662-E4EDF2AD-9E82-4C98-AF91-E94424FF86E3Q47445453-70960DF6-33C4-4687-95B9-84A7EE05BF2CQ47445746-5333E21A-FCD1-422F-9A92-3CFB66BFEE01Q48147772-CC704DF9-D5D9-4245-A90B-0FD8B174717AQ52906269-C9E2EC9E-C588-493A-81B7-1BE6929C5916Q55094703-3D23E4D7-71BB-465D-A9C4-C3F7803E0AFB
P2860
Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@en
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@nl
type
label
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@en
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@nl
prefLabel
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@en
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@nl
P2093
P2860
P1476
Elevated preconception CD56+ 1 ...... bfertile women undergoing IVF.
@en
P2093
Edward E Winger
Jane L Reed
Mohamed Taranissi
Sapna Ahuja
Sherif Ashoush
Tarek El-Toukhy
P2860
P304
P356
10.1111/J.1600-0897.2011.01018.X
P577
2011-05-30T00:00:00Z